TCNU (LS-2667), A NEW ACTIVE-DRUG IN THE TREATMENT OF ADVANCED COLORECTAL-CANCER

被引：9

作者：

GUNDERSEN, S

DOMBERNOWSKY, P

CAVALLI, F

BRUNTSCH, U

RENARD, J

VANGLABBEKE, M

PINEDO, H

机构：

[1] UNIV COPENHAGEN HOSP,DK-2100 COPENHAGEN,DENMARK

[2] OSPED SAN GIOVANNI,BELLINZONA,SWITZERLAND

[3] MED KLIN 5,NURNBERG,FED REP GER

[4] EORTC DATA CTR,B-1000 BRUSSELS,BELGIUM

[5] FREE UNIV AMSTERDAM HOSP,AMSTERDAM,NETHERLANDS

来源：

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1989年 / 25卷 / 07期

关键词：

D O I：

10.1016/0277-5379(89)90394-5

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1095 / 1097

页数：3

共 7 条

[1]

HARTLEYASP B, 1988, INVEST NEW DRUGS, V1, P19

[2]

KEMENY N, 1980, NEOPLASMS COLON RECT, P155

[3]

MARSONI S, 1987, CANCER TREAT REP, V71, P71

[4] PHASE-I STUDY OF TCNU, A NOVEL NITROSOUREA [J].

SMYTH, JF ;

MACPHERSON, JS ;

WARRINGTON, PS ;

KERR, ME ;

WHELAN, JM ;

CORNBLEET, MA ;

LEONARD, RCF .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (12) :1845-1849

[5] A PHASE-I CLINICAL-EVALUATION OF 1-(2-CHLOROETHYL)-3-[2-(DIMETHYLAMINOSULPHONYL)ETHYL]-1-NITROSOUREA (TCNU) [J].

VIBEPETERSEN, J ;

BORK, E ;

MOLLER, H ;

HANSEN, HH .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (12) :1837-1843

[6]

WASSERMAN TH, 1975, CANCER, V36, P1258, DOI 10.1002/1097-0142(197510)36:4<1258::AID-CNCR2820360411>3.0.CO

[7]

2-6

← 1 →